BE497828A - - Google Patents
Info
- Publication number
- BE497828A BE497828A BE497828A BE497828A BE497828A BE 497828 A BE497828 A BE 497828A BE 497828 A BE497828 A BE 497828A BE 497828 A BE497828 A BE 497828A BE 497828 A BE497828 A BE 497828A
- Authority
- BE
- Belgium
- Prior art keywords
- salt
- ephedrine
- heparinic
- weight
- acid
- Prior art date
Links
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims description 16
- 229920000669 heparin Polymers 0.000 claims description 12
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 11
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 claims description 7
- 229960002179 ephedrine Drugs 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 2
- 230000001371 heparinic effect Effects 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims 1
- 230000008020 evaporation Effects 0.000 claims 1
- 230000023555 blood coagulation Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE497828A BE497828A (d) | 1949-09-14 | 1950-08-30 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA497828X | 1949-09-14 | ||
CH497828X | 1950-07-27 | ||
BE497828A BE497828A (d) | 1949-09-14 | 1950-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE497828A true BE497828A (d) | 1950-09-25 |
Family
ID=140690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE497828A BE497828A (d) | 1949-09-14 | 1950-08-30 |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE497828A (d) |
-
1950
- 1950-08-30 BE BE497828A patent/BE497828A/fr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH469659A (fr) | Procédé d'obtention de dérivés du tri-hydroxy-méthyl-aminométhane | |
BE497828A (d) | ||
US2117207A (en) | Amino acids | |
SU106378A1 (ru) | Способ получени 4-амино-5-формиламино-урацила | |
CH370093A (fr) | Procédé pour la préparation de dérivés de l'acide diamino-caproïque | |
SU322049A1 (ru) | СПОСОБ ПОЛУЧЕНИЯ 17а-АЦЕТАТА 3-МЕТИЛОВОГО ЭФИРА | |
US3657228A (en) | Process for the manufacture of 3beta-hydroxy-5beta-cardenolides | |
BE633559A (d) | ||
US2680739A (en) | Production of sodium penicillin | |
CH405333A (fr) | Procédé de préparation de sels du bis (amidino-4'-phénoxy-1,5-pentane | |
BE504872A (d) | ||
CH402842A (fr) | Procédé de préparation de nouveaux dérivés de l'héparine | |
CH259253A (fr) | Procédé de préparation de l'oléate d'acétylcholine. | |
BE827580A (fr) | Preparation de d et l-2-amino-1-butanol | |
BE482618A (d) | ||
CH289890A (fr) | Procédé de pr<paration d'un acylamidodiol aromatique. | |
CH309341A (fr) | Procédé de préparation de dichlorure de 5,5'-bis(triméthylammonium)-dipentyléther. | |
Goldberg | 152. Isethionic acid | |
BE491329A (d) | ||
BE688978A (d) | ||
CH360694A (fr) | Procédé de préparation de sels de l'acide N-acétyl a-aminoisocaproïque | |
CH299940A (fr) | Procédé de préparation d'un dérivé de la pyrimidine. | |
CH292943A (fr) | Procédé de préparation d'un nouveau composé chimique à activité thérapeutique. | |
CH339702A (fr) | Procédé de préparation de sels de pénicillines | |
BE635463A (d) |